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In adult rats, antagonisni of the 5-HT3 serotonin receptor blocks

the acquisition Of a morphine-induced conditioned place preference

(CPP). In the present study, the ability of the selective 5-HT3 serotonin
receptor antagonist MDL-72222 to modulate the acquisition and

expression of cocaine- and morphine-induced CPP was assessed in 17-day
old rats. An abbreviated CPP procedure was used in which rats received
two saline-odor (lemon or almond^ pairings on the first conditioning

day, and two saliner, cocaine-, or morphine-odor pairings on the second

day. Preference was assessed on the third day. To determine the effects of
5-HT3 receptor antagonism on the acquisition of CPP, rats were given
MDL-72222 (0.5-4.5 mg/kg), IP) 30 min prior to being conditioned with

cocaine (20.0 mg/kg, IP) or morphine (0.5 mg/kg, IP). To determine the

effects of 5-HT3 receptor antagonism on the expression of CPP, rats were
injected with MDL-72222 30 min prior to preference testing. As expected,
both cocaine and morphine produced robust place preference

cohditioning in preweanling rats. Surprisingly, MDL-72222 did not affect
the acquisition or expression of cocaine- or morphine-induced CPP. These
results suggest that the 5-HT3 serotonin receptor system may

differentially modulate DA- and opioid-mediated reward across

ontogeny. The known peak surge in the density of certain dopamine

-.iii; ■ .

receptor subtypes within the mesolimbic system coincide with the

preweanling stage of development. An animal's ability to acquire and
express memories and behaviors related to rewarding experiences
depends upon the robust functioning of the reward center. The mastery
required to survive the weaning period may depend upon a temporary
alteration in neurotransmisson that reduces the risk of lowering reward
functioning.
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OVERVIEW

Science is revealing that a homeostasis exists within an
individual's normal brain chemistry. Disruption of the functional

stability between the levels of various neurochemicals can lead to

temporary or permanent disease. No area of the brain is more important
to an individual's psychological health than the mesolimbic system
(Davis, Kahn, Ko, & Davidson, 1991). This system has been implicated in

the sense of mental well being and in the reinforcement properties of
drugs of addiction (Nathan, Dominique, Schatzberg, & Nemeroff, 1995;
Wise & Bozarth, 1987).

Evidence from several experimental paradigms have implicated

the dopamine (DA) pathway in an endogenous system of reward
(Ettenberg & Camp, 1986; Olds, 1978). Instrumental conditioning,

operant conditioning and conditioned place preference (CPP) studies
have suggested that DA neurotransmission is essential for the
establishment of the natural reinforcement properties of satiation, as

well as the addictive qualities of substances of abuse (Beninger et al.,

1987; Fibiger & Phillips, 1982; Wise & Bozarth, 1987; Wise, Spindler, &

Legault, 1978). Additionally, both the acquisition and expression of
conditioned behaviors are shown to be mediated by separate DA receptor

mechanisms (Hiroi & White, 1989, 1990; Spyraki, Fibiger, & Phillips,
1982a; White & Garr, 1984, 1985).

Through manipulations of the specific neurochemicals that are
involved in reinforcement, the reward pathway has been shown to be

stimulated by drugs that activate DA neurons, causing DA release into
the nucleus accumbens (NA) (deWit & Wise, 1978; DiChiara & Imperato,

1988; DiChiara & North, 1992; Grant, 1995; Gysling & Wang, 1983;

Shippenberg, Bals-Kubik, & Herz, 1993; Wise & Bozarth, 1987). Addictive
drugs that excite the DA reward system, such as morphine and cocaine^
allow the acquisition and expression of reward; whereas, neurochemicals
that antagonize DA neurotransmission appear capable of suppressing
reward (Calcagnetti, Keck, Quartrella, & Schechter, 1995; DiChiara &
North, 1992; Hoffman, 1989; Wise & Bozarth, 1987). The expression of
reinforced behavior is believed related to the mnemonic aspects of

reward, possibly through afferents coming into the NA from the
amygdala (Hiroi & White, 1991).

Thus, DA maintains a central place of importance in the reward

process (DiChiara & Imperato, 1988) In addition to the role played by
mesolimbic DA neurons and their fiber pathways, evidence has

implicated the existence of other neurotransmitters within the reward
system (Costall, Naylor, Mardens, & Pycock, 1976; DiChiara & North,
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1992). For example, both the serotonin and opioid systems modulate the
DA reward pathway. These two neurotransmitter systems have been

implicated in the normal functioning of reward mechanisms and may
impact the effects that addictive drugs have on behavior (Costall et al.,
1976; DiChiara & North, 1992; Imperato & Angelluci, 1989; Spahagel,
Herz, & Shippenberg, 1992). Consequently, experimental research has

begun to focus on the role played by serotonin in the reward process
(Grant, 1995; Imperato & Angelucci, 1989). Studies of serotonin agonists
and antagonists have provided evidence that the serotonin receptor is

important for reward. Antagonism of the serotonin receptor subtyjpe 5

HTs appears to abolish drug-induced reward (Joharchi, Sellars, & Higgins,
1993; Suzuki, Shiozaki, Masukawa, & Misawa, 1992). This suggests that

serotonin regulates mesolimbic DA neufotransmissiOn (Carboni, Acquas,
Frau, & DiChiara, 1989; Imperato & Angelucci, 1989).

There are indications that a functioning reward system exists in

preweariling rats, although some interesting age-dependent differences
have been reported (McDougall, Nonneman, & Crawford, 1991). Evidence

indicates that in addition to a fairly mature endogenous reward system,
neonates also have the ability to respond to drugs with reinforcing

properties. Morphine and cocaine enhance DA levels in preweanling rats,
an effect that also enhances reinforced behaviors. Consequently,

blockade of DA receptors attenuates the reinforcing properties of drugs

like morphine and cocaine (Barr & Rossi, 1992; Laviola, beU'Omo, Alleve,
& Bignami, 1992; Pruitt, Bolanos, & McDougall, 1995).
It also appears that preweanling rats have a fully developed
serotonin system, as receptor binding studies demonstrate' that serotonin

receptors are in place and functioning shortly after birth (Daval et al.,
1987; Laviola et al., 1992; Pranzatelli, 1992). However, little is known
about the interaction between the DA and serotonin systems in the

preweanling rat, so it is uncertain whether the sefotonin system

modulates reward functioning in these young animals. Additionally, it
has never been determined what brain areas are responsible for
serotonin's reward attenuation abilities or whether separate mechanisms

control the acquisition and expression of reward. Therefore, the purpose
of this project is: first, to determine whether serotonin 5-HT3 receptor
antagonists will block both the acquisition and expression of DA and

opiate reward and, second, to determine what brain areas are critical for
serotonin's reward suppressing effects

INTRODUCTION

DA is enormously important to psychological welTbeing (Kapur «&

Remington, 1996). Pathology in DA pathways have been implicated in
mood disorders (Nathan et al., l995), the disordered thought and affect

in schizophrenia (Davis et al , 1991), the involuntary tier and co
of Tourette's disorder (Malison et al;, 1995), the motor impairments of

Parkinson's disease (Agid, 1991; Balk et al., 1995), the inattention and

hyperactivity in children with attentibn-deficit hyperactivity disorder
(ADHD) (Castellanos et al., 1994) and in the paranoid symptoms of
Alzheimer's disease (Nazarali & Reynolds, 1992). DA levels within the

mesolimbic DA reward pathway have also been directly implicated in

the rewarding properties of drugs of abuse (Wise & Bozarth, 1987). The
many devastating abnormalities in behavior that result from a
disruption of DA neurotransmission indicates its immense importance to
normal functioning.

Although the exact causes of schizophrenia, Alzheimer's Disease,
Tourette's Disorder and ADHD remain unknown, many of the symptoms

are alleviated by antagonism or agonism of DA system functioning. DA

receptor antagonists, such as chlorproinazihe and haloperidol, are used
to alleviate the psychotic symptoms of schizophrehia and Alzheimer's
disease (Davis et al., 1991; Nazarali & Reyhblds, 1992). Syinptoms of

Tourette's syndrome are also alleviated by DA antagonists (Malison et
al., 1995). Methylphenidate, an indirect DA agonist related to

amphetamine, is used successfully to treat many cases of ADHD
(Castellanos et al., 1994).

Many addictive drugs activate the DA system. Research utilizing
animal models of reward have implicated DA neurotransmission in the

rewarding effects of drug addiction (Bozarth & Wise, 1981; Hoffman,
1989; Wise, 1983). For example, systemic or localized injections of
addictive drugs, such as morphine, cocaine and amphetamine, increase
DA levels within the mesolimbic region of the rat brain (DiChiara &

Imperato, 1988; Wise & Bozarth, 1987). Conversely, antagonism of DA

receptors inhibits DA release and attenuates drug-induced behaviors in
rats (DiChiara & Imperato, 1988; Rompre & Wise, 1988; Yokel & Wise,
1976).

Thus, DA neurotransmission appears to have an important role in

normal functioning. Diseases of the nervous system or drug-induced
imbalances can cause disruptions in the DA pathways resulting in
pathological behaviors.
BASIC STRUCTURE AND FUNCTION OF DA PATHWAYS

The DA system has a highly organized arrangement of projections
that are classified into the nigrostriatal and mesolimbic-mesocortical

systems. The nigrostriatal system primarily extends from the substantia

nigra to the striatum (i.e., caudate-putamen). Additional DA fibers

project from the ventral tegmental area (VTA) to either the limbic
system (to form mesolimbic connections) or to the cortex (to form
mesocortical connections) (Grant, 1995; Kandel, Schwartz, & Jessell,

1995; Nicholls, Martin, & Wallace, 1992; Phillips, 1984; Routtenberg, 1978;

Wise & Rompre, 1989). Although frequently considered together, the
mesolimbic-mesocortical systems will be discussed separately to simplify
discussion (see Figure 1).
Nigrostriatal Fathwav

The nigrostriatal system is formed by DA neurons that originate in
the substantia nigra and project to several striatal sites, including the

caudate-putamen, subthalamic nucleus and the globus pallidus. The rat
substantia nigra has 7000 DA cells which contain over 250,000 processes
extending into the caudate-putamen (Nicholls et al„ 1992). When the
neurons are activated, DA is released at the terminals and mediates the

voluntary control of movement (Kandel et al., 1995). Parkinson's disease,
which is characterized by muscle rigidity, tremor and difficulty in

initiating movement, occurs when the DA cells of the nigrostriatal
pathway degenerate (Agid, 1991).
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Figure 1 . Dopamine Pathways: Coronal and Lateral.

Mesocortical

Pathway

The DA eells of the mesocortical system primarily have their origin

in the ventral tegmentum (Area 10). Their projections extend to the
cerebral cortex where they are thought to contribute to cognition (Kandel
et al., 1995; LeDoux, Iwata, Cicchetti, & Reis, 1988). DA fiber projections

are most dense in the prefrontal cortex, where the functions of

motivation and planning are believed to occur (Fibiger & Phillips, 1986,
1988.; Goeders & Smith, 1983).

The temporal organization of behavior, attention and social

responses may also be modulated by activity in this pathway
(Castellanos et al., 1994). Much research indicates that an interaction
exists between the cortical and subcortical DA systems, through fiber

connections traversing both regions. A reduction in prefrontal DA
innervation causes increased activity in subcortical brain areas (Deutch,

Clark, & Roth, 1990; Gariano & Groves, 1988; Kandel et al., 1995;

Nicholls, 1992). Afferents from the prefrontal cortex are believed to make

synaptic connections with dopaminergic structures in the VTA (Deutch
et al., 1990). Moreover, prefrontal afferent fibers are in close proximity to

tyrosine hydroxylase positive terminals within the mesolimbic pathway
(Sesack & Pickel, 1992). This suggests that the cortex and the mesolimbic

system do not function in isolation from one another: Drugs that impact

one may exert changes on the other.
Furthermore, it has also been demonstrated that activation of the

prefrontal cortex directly increases dopaminergic activity within noncortical DA pathways (Gariano & Groves, 1988; Murase, Mathe, Grenhoff,
& Svensson, 1993; Taber & Fibiger, 1993). In contrast, input going from

the dopaminergic system to the prefrontal cortex appears to be
inhibitory (Jaskiw, Weinberger, & Crawly, 1991; Louilot, LeMoal, & Simon,
1989). A reduction in prefrontal dopaminergic activity results in

increased activity and/or heightened sensitivity within the mesolimbic

region (Deutch et al, 1990; Haroutunian, Kanof, & Davis, 1989; Pycock,
Kerwin, & Carter, 1980; Rosin, Clark, Goldstein, Roth, & Deutch, 1992).
Mesolimbic

Pathwav

The mesolimbic system is critically involved in reward. This

system is composed of DA cell bodies that are found in the VTA and the
axons of these DA neurons extend into the NA and amygdala. Therefore,
activation of cell bodies in the VTA results in increased DA release from

terminal fibers in the NA and the amygdala (DiChiara & Imperato, 1988;
Hiroi & White, 1991b; Phillips, 1984; Routtenberg, 1978; Wise & Rompre,

1989). The neural input into the VTA is from the medial forebrain
bundle (MFB). When the MFB is stimulated, it excites non-dopaminergic

fibers which synapse on DA neurons in the VTA and substantia nigra

10

(Shizgal & Murray, 1989) (see Fig^^
DA Receptors

Following its release from the DA terminal, DA neurotransmitter
binds to specific receptor sites (see Figure 3). These receptors are

classified according to similarities in genetic Structure and ~the presence
of common second messenger mechanisms. One family of DA receptors

comprises the Di and D5 subtypes. The Di receptors are found in the

mesocortical system. The second family of DA receptors is called D2 and
also includes the D3 and D4 types.

The DA receptor prominent in the nigrostriatal system is the D2

subtype, whereas D3 and D4 receptors are primarily distributed in the
mesolimbic system. Presynaptic DA receptors appear to be localized in
two main areas: one is on DA cell bodies in the mesolimbic region (called

somatodendritic autoreceptors), where they modulate the firing of DA
neurons; the second is on DA axonal terminals (called terminal

autoreceptors), where they modulate release of DA (Cooper, Bloom, &
Roth, 1991; deKeyser, 1993).
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Qpioid Structures Within The Mesolimbic system

Opioid receptors and natural opioids, called enkephalins and
endorphins, are found in abundance within the mesolimbic system
(Kalin & Loevinger, 1983; Spanagel, 1995). Binding studies demonstrate

that opioid and DA receptors are co-localized in the^ VTA and fibers
containing enkephalin are found together with DA neurons (Manzanares,

Lookingland, & Moore, 1991; Morel & Pelletier, 1986). Some of the opioid

receptor subtypes have been implicated in the mediation of mesolimbic
DA functioning (DiChiara & Imperato, 1988; Mansour, Khachaturian,
■ ■

■

.

.

'

Lewis, Akil, & Watson, 1988).

Opiate receptor binding sites and their corresponding
neurotransmitters are divided into three major subtypes called mu (p.),

delta (6) and kappa (k) (Lord, Waterfield, Hughs, & Kosterlitz, 1977).
Morphine and met-enkephalin have a high affinity for p receptors,
whereas leu-enkephalin preferentially binds to 6 receptors. D-ala-met

enkephalin, a specific p receptor agonist is found to bind directly to

endogenous opiate met-enkephalin p receptors localized in the VTA

(Satoh & Minami, 1995). However, mRNA studies have found evidence for
the presence of p receptors in both the VTA and the NA (Azaryan,
Coughlin, Buzas, & Cox, 1996). High concentrations of the endogenous 6
neurotransmitter leu-enkephalin and 6 receptors are also found in the

14

NA and the VTA (Mansour at aL, 1988; Satoh & Minami, 1995). k

receptor sites are located within many brain regions including the NA,
VTA, medial prefrontal cortex and lateral hypothalamus (Bals-Kubik,
Ableitner, Herz, & Shippenberg, 1993). k receptors are bound by

deltrophins and research suggests that they are importantaversive stimulation (Erspamer et al., 1989).

When It receptors are bound by an agonist, they activate DA
neurons in the mesolimbic pathway (see Figiire 4). Specifically,

activation of those |t receptors located on GABAergic in'temeurons in the
VTA inhibits the release of GABA (Brady, Herkenham, Long, & Rothman,
1989; La Motte, Snowman, Pert, & Snyder, 1978).

These GABA neurons normally inhibit the DA fibers of the

mesolimbic pathway, so a lack of GABA activation prevents the
inhibition of DA neurons and, indirectly, results in DA activation

(DiChiara & North, 1992; Klein et al., 1993). Microdialysis studies

indicate that when opiates bind to |i receptors, an activation of
mesolimbic DA neurons occurs (DiChiara & Imperato, 1988). Specifically,

when morphine is injected exclusively into the VTA, DA neurons are

activated causing increases in DA levels within the NA (DiChiara &
Imperato, 1988).

1,5.-^,

r-igure 3

Model of Morphine's DisirLhibition of
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10 mv '
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Morphine enhances DA activity if given either systemically or

locally injected into the VTA, but not when morphine is injected directly
into the NA. A model describing the modulation of the mesolirhbic

system by two opposing opioid systems has been constructed by
Spanagel et al. (1992). They propose that the DA neurons projecting to
the NA can be disirihibited by p.-opioid feceptors located on those GABA

inhibitory interneurons in the VTA (see Figure 4). The disinhibition of
the DA neurons causes a measurable increase in NA DA release, which is

reflected in behavior (Spanagel et al., 1992). Whereas, the activation of k-

opioid receptors located in the NA results in the inhibition of DA release
and has aversive and sedative effects on behavior (Spanagel et al., 1992).

In summary, the mesolimbic DA system, whose DA neurons arise in
the VTA and extend their axons into the NA, has been implicated in the

mediation of reward (Ettenberg, 1989; Wise, 1983; Wise & Rompre^ 1989).

p and 6 opioid receptors enhance DA function by disinhibiting the DA
neurons of the mesolimbic pathway, whereas k receptors directly inhibit
DA release in the NA (DiChiara & North, 1992; Klein et al., 1993; Spanagel
et al., 1992).
PHARMACOLOGY OFREWARD

Animal research suggests that the brain has natural reinforcement
mechanisms, with both endogenous DA and opioid processes modulating
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reward (Olds & Milner, 1954; Salamone, Cousins, McCullough, & Carriera,

1994; Shizgal & Murray, 1989; Wise, 1983). There is a large amount of
evidence that the mesolimbic DA pathway is responsible for the

reinforcing effects of natural rewards such as food and water. There is
also considerable support for the role played by the DA pathway in the
reinforcement properties of addictive drugs. The inost important

paradigms assessing reward are the instrumental conditioning, operant
conditioning, and CPP paradigms (Ettenberg & Camp, 1986; Hoffman,
1989; Wise & Rompre, 1989).
DA REWARD

Instrumental Conditioning

Studies

Utilizing the instrumental conditioning paradigm, several
laboratories have investigated the reinforcing effects of food and water

consumption by challenging DA receptors with antagonists (Ettenberg &

Camp, 1986; Ettenberg & Horvitz, 199G; Ettenberg, Koob, & Bloom, 1981;
Ljungberg & Ungerstedt, T979). In a study that examined the role of DA
in water reward, an experimental group received a pretreatment of either

pimozide or haloperidol (DA receptor antagonists). Response times of
untreated, water deprived animals was faster when compared to thirsty
rats that had been pretreated with DA antagonists (Ettenberg & Camp,
1986; Ettenberg & Horvitz, 1990).
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Researchers also used DA antagonists to challenge the reinforcing

properties of food reward. Blockade of DA receptors by haloperidol

reduced response times and running speeds of rats towards a food
reward. Apparently, the reinforcement value of food pellets was
effectively suppressed by DA.antagonists, reducing the importance of the

anticipated reward (Ettenberg & Camp, 1986). Thus, through DA
antagonism, the reinforcement qualities of food and water reward could
be attenuated in the runway paradigm (Ettenberg & Camp, 1986;
Ettenberg & Horvitz, 1990).

Importantly, other researchers have contended that drug-induced
motor deficits, rather than reward diminution, could account for the

decrease in reinforced responding (Ettenberg, Koob, & Bloom, 1981;

Ljungberg & Ungerstedt, 1979). To assess the possibility of a motor
confound, experimenters either tested rats in a non-drugged state or
utilized an extinction paradigm to confirm that DA antagonism does
attenuate reinforced responding. For example, while testing water reward
in a non-drugged state, Ettenberg and Horvitz (1990) demonstrated a
reduced running speed in thirsty rats. Because the animals were
evaluated 24 hours after DA antagonist treatment, it confirmed that the

attenuation of the reinforced response was not related to drug-induced

motor impairments (Ettenberg & Horvitz, 1990). Other experiments
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utilized the extinction paradigm to verify DA attenuation of food
reward. Rats treated intermittently with DA antagonists demonstrated
resistance to extinction, despite the presence of continuous food reward

(Ettenberg & Camp, 1986; Salamone, 1986). Therefore, when considered

together these results suggest that DA antagonists^M
of food and water reinforcers.^ ^

reward value

:

Utilizing the instrumental conditioning paradigm, sevefal
researchers attempted to determine which DA receptor subtypes were

respoiisible for natural reward (Fowler, Liou, Rusk & Cooper, 1994; Wise,

Spindler, DeWit, & Gerber, 1978b). One study found evidence that the
mixed D1/D2 antagonists fluphenazine and pimozide, the Di antagonist
SCH 23390, and the D2 antagonist raclopride all signifioantly blocked the

response to food reward (Fowler et al, 1994; Wise, Spindler, DeWit, &
Gerber, 1978). These studies suggest that both the Di and D2 receptors
are involved in reward.

Operant Conditioning Studies

Manipulations of the reward pathway by various agonists and/or
antagonists has become a useful method for studying reward system

functioning (Beninger et al., 1987; Wise, Spindlef, DeWit, & Gerber, 1978).
Because animals possess a natural desire to seek food, they readily learn
to lever-press to obtain food pellets. Mot surprisingly, the DA antagonist

pimozide, which has been used to suppress instrumental conditioned
responding, also significantly attenuates operant conditioning for food
(Beninger et al., 1987). Recent microdialysis studies confirm the role

played by DA in the consummatory responses of food intake. Rats

responding at a high rate for food reinforcement show a significant
increase in extracellular DA and DA metabolites in the NA (Ettenberg &

Camp, 1986; Salamone et al., 1994). Similarly, Kiyatkin and Gratton
(1994) found increased NA DA levels shortly after cues were presented

that signaled access to the food-lever. DA levels continued to increase as
the subjects earned food reward. These DA levels remained high until

lever pressing ceased, causing DA to return to basal levels (Kiyatkin &
Gratton, 1994).

The opefant conditioning paradigm has also been used to examine

which DA receptor subtypes are involved in reward functioning. For
example, operant conditioning for food reward is blocked by either Di
and/or D2 receptor antagonists, indicating that both Di and D2 receptors
are involved in reward (Beninger et al., 1987; Nakajima & Baker, 1989).

Not surprisingly, injecting the selective Dj DA antagonist SCH 23390 into
the NA also results in the inhibition of lever-pressing for food (Beninger et

al., 1987). Thus, DA antagonist studies show that the DA system is

critically involved in reward and that both the Dj and D2 receptors are
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necessary for normal reward functioning.

DA Agonists and Qperant Conditioning
Much of the work with psychomotor stimulant drugs, such as

cocaine and amphetamine, have jprovided evidence that DA systems are

involved in mediating the reinforcing properties of those drugs (Pettit,

Ettenberg, Bloom, & Koob, 1981; Yokel & Wise, 1976). Rats continue to
self-administer cocaine and amphetamine unless a DA antagonist is
administered or the DA terminals in the NA are destroyed by toxic lesion
(Yokel & Wise, 1976). Although amphetamine- and cocaine-induced
reward correlates >vith an increase in extracellular DA in the NA, the

mechanisms of these drugs appear to differ (DiChiara & Imperato, 1988;

Ritz, Lamb, Goldberg, & Kuhar, 1987). Specifically, cocaine increases DA
levels by blocking DA reuptake (DiChiara & North, 1992; Ritz et al., 1987;
Svingos, Strecker, McNeish, & Hitzemann, 1991), whereas amphetamine
increases DA release from the terminal fibers (DiChiara & Imperato,
1988).

Recently, Di receptors located in the NA have been directly

implicated in the reinforcing effects of cocaine. Rats were given localized
NA injections of a selective Di antagonist to evaluate DA involvement in
the reinforcing properties of cocaine. The antagonism of this receptor
caused significant increases in cocaine self-administration, which
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suggests that Di receptors in the NA modulate cocaine selfadministration (Maldonado, Robledo, Chovef, & Caihe, 1993). Curiously,

Calcagnetti et al. (1995) have found thm ndn--dopaminergic receptor
antagonists can successfully attenuate cocaine's actions. They include
calcium channel blockers, 5-HT3 antagonists, and Opiate antagonists.

There is much speculation about the underlying mechanisms by which

these drugs attenuate cocaine's actions. One possibility is that these

drugs regulate ion flow through neuronal membrane channels
(Calcagnetti et aL, 1995; Menkens et aL, 1992). For example, calcium
blockade itself causes an attenuation in DA levels (Martellota, Kuzmin,
Muglia, Gessa, & Fratto, 1994).

In summary, 0perant conditioning studies provide excellent
evidence of DA's role in reward. DA antagohists significantly attenuate

operant conditioning for reward (Beninger et al., 1987; Wise, Spindler,
DeWit, & Gerber, 1978). Microdialysis and electrochemical examination
of mesolimbic DA activity also supports DA's involvement in conditioned

behaviors (Ettenberg & Camp, 1986; Kiyalkin & Gratt^^ 1994; Salamone
et al., 1994), Although there is some disagreement as to the exact DA

subtypes involved in reward, most agree that both Di and D2 receptors

are necessary for its expression (Beninger et al., 1987; Nakajima & Baker,
1989; Phillips et^ a^^^^^

CPP

Along with instrumental eonditioning and operant conditioning
studies, CPP experiments implicate the mesolimbic DA system in druginduced reward. Although instrumental conditioning and operant

studies have provided considerable amounts of information on the
neural substrates involved in reward, the disadvantage of these

procedures is that animals must perform complex maneuvers while still
under the influence of the drug (Ettenberg, 1989). The CPP paradigm

eliminates this problem because conditioned animals are in a non-

drugged State during testing (Bozarth, 1987; Schecter & Calcagnetti,
1993).

In the CPP paradigm rats are given a drug and confined to one side
of a two compartment chamber (these compartments are visually and

tactilly distinct). On the subsequent day the same rat is given saline and
confined in the opposite chamber. After a number of trials, the animal is

tested in the drug free state and their compartment preference is
assessed. This paradigm eliminates the possible interference of motor
effects caused by testing in the drug-induced state (Schecter &

Calcagnetti, 1993). Evidence indicates that CPP can be established in rats

by Systemic injections of cocaine, amphetamine, and morphine. This
reinforced behavior can be blocked by haloperidol and reduced by 6
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OHDA lesions (Hawkins & Stein, 1991; Reicher & Holntah, 1977; Sherman,

Roberts, Roskam; & Holman, 1980; Spyraki, Fibiger, & PM

1982a; Wise

& Rompre, 1989). Studies have also shown that DA neurotransmission is
essential for the establishment of the reinforcing properties of food

reward, as well as the addictive qualities of Substances of abuse'(Be

et al., 1987; Fibiger & Phillips, 1982; Wise, Spindler, & Legault, 1978; Wise
& Bozarth, 1987).

Evidence indicates that reward is actually two separate processes

that are controlled by, and function differently within the mesolimbm

system (Hiroi & White, 1991a, 1991b; White & Carr, 1984, 1995). The

acquisition and expression of reward behaviors are mediated bydifferent
receptor mechanisms (Hiroi & White, 1989; 1990, 1991a; Spyraki, Fibiger,
& Phillips, 1982a; White & Carr, 1984, 1985). The acquisition of a CPP
involves the pairing of environmental stimuli with drug-induced
mesdlimbic DA

Whereas, the expression of a previously

established CPP can be activated by conditioned stimuli, which are

originally paired with events that had evoked the unconditioned release
of DA. These two mechanisms (i.e., acquisition and expression) are

dissociable. For example, acquisition and expression can be individually

blocked by antagonists of different DA recpptor subtypes (White & Carr,
1984, 1985). The acquisition of CPP appears to be dependent upon
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activation of DA neurons within the VTA, resulting in DA release in the

NA. Microinjections of DA agonists in this area results in CPP acquisition,
and it is attenuated by the depletion of DA

within the NA

(DiChiara & Imperato, 1988; Spyraki et al.,1982b). Studies of the
expression of a previously established drug-induced CPP demonstrate
that it can be blocked through the systemic, or NA injection of DA

antagonists (Hiroi and White, 1989, 1990; Spyraki et al., 1982b). When
selective DA antagonists are injected following conditioning trials, the

expression of CPP on the drug-free test day is effectively blocked (Hiroi &
White, 1991a, 1991b).

More specifically, when conditioned stimuli (i.e., a scented or

visually distinct chamber) are paired with an unconditioned stimulus
(i.e., the DA release caused by the addictive drug), the conditioned
stimuli eventually acquire the property of evoking DA neuronal
activation. Thus, when the animal encounters conditioned stimuli in the

absence of the drug, an elevation of DA metabolism is observed in the
terminal area of the mesolimbic system (Hiroi & White, 1990, 1991a).

This is thought to be the expression of the conditioned response.

Evidence suggests that Di receptors located in the NA mediate the

expression of CPP behavior (Hiroi & White, 1991a; White, Packard, &
Hiroi, 1991). In contrast, evidence indicates that D2 receptors in the NA
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mediates the aequisition of the uncoiiditioned effects of the addictive

drug (Hiroi, McDonald, & White, 1990; Hiroi & White, 1989, 1990, 199la,
1991b). This possibly explains why DA release is still observed when rats

are given D2 antagonists after cocaine and amphetamine treatment
(Hiroi & White, 1991a; Ritz et al, 1987). The Di mediated conditioned
reinforcers are not blunted by D2 antagonists.
Further evidence suggests that the expression of conditioned
behavior is also mediated through intrinsic neurons of the lateral

nucleus of the amygdala, because NMDA toxic or electrolytic lesions

made to this region attenuates amphetamine-induced CPP (Hiroi &
White, 1991b). Afferents that target the NA project from the amygdala,

hippocampus, entorhinal cortex, and the cerebral cortex (among others)
(Kelley, DomesiCk, & Nauta, 1982; Phillipson & Griffiths, 1985; Sorenseh &
Witter, 1983) (see Figure 1 and 3). However, it is the amygdala and

hippocampus that have been specifically implicated in memory, and
lesions to these two regions cause deficits in several types of memory
tasks (Peinado-Manzano, 1990; Sutherland & McDonald, 1990). In fact,
Hiroi and White (1991) discovered that expression of amphetamine-

induced CPP is mediated by intrinsic neurons of the lateral nucleus of

the amygdala, since their destruction effectively prevents the expression
of GPP reward (Hiroi & White, 1991b). This suggests that DA afferents
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connecting the lateral nuciens of the amygdala and the NA, are
responsible for the expression of CPP. Furthermore, 5-HT3 receptors
localized to the airiygdala have recently been implicated in the
modulation of reward (Dyr & Kostowski, 1995).

Although both the acquisition and expression of conditioned
behaviors are mediated by DA receptor activation, different subtypes
modulate these mechanisms (Hirbi & White, 1989, 1990; Spyraki, Fibiger,

& Phillips, 1982a; White & Carr, 1984, 1985). Studies have demohstrated
that the drug-induced acquisition of CPP can be attenuated when D2

antagonists are given prior to the DA agonist during conditioning
sessions. This inhibits the acquisition of GPP, as demonstrated by the rat

showing no preference behavior on the drug-free test day (Hiroi & White,
1989; Spyraki, Fibiger, & Phillips, 1982a). Surprisingly, the acquisition of

amphetamine-induced CPP can be initiated by the injection of selective
agonists of either Di or D2 receptors located within the NA. When
antagonists of either subtype are injected before conditioning, the

acquisition of CPP is blocked (Hoffman & Beninger, 1989; Leone &
DiChiara, 1987; Spyraki, Fibiger, & Phillips, 1982a) (see Figure 5). In
contrast, the expression of previously established CPP can be inhibited by

systemic or intracranial NA injections of Di antagonists just prior to the
drug-free test trial.

BLOGJ^ING ACQUISITION

DA Antagonist Is Given Dufing Morpliine- Or
Cocaine-induced Conditioned Place Preference (CPP)
Injection of

da Antagonist

CPP

Acquisition

Is Blocked

BLOCKING EXPRESSION

DA Antagonist Is Given After Morpbine- or Cocaine-induced
Conditioned Place Preference (CPP)
Ezpression
Is Blocked
injection of

A Antagonist

BLOCKADE OF THE ACQUISITION OR EXPRESSION OF CPP
Figure 5 Blockade Of CPP Acquisition Or Expression.
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Furthermore, evidence indicates that antagonists of the D2 receptor

subtype are unable to block the expression of drug-induced CPP when
injected following conditioning. Only antagonists of the Di receptor can

prevent the expression of a previously established amphetamine-induced
CPP (Hiroi «& White, 1991).

The acquisition of CPP by cocaine has shown a similar complexity
of action. Although cocaine-induced CPP can be blocked by the DA

antagonist pimozide, it appears that the neural mechanisms mediating
cocaine-induced CPP are complicated (deWit & Wise, 1978; Goeders &
Smith, 1983). For example, some neuroleptics have no effect on the

acquisition or expression of cocaine-induced CPP.

More specifically, haloperidol does not block cocaine-induced CPP
except at very high doses, whereas low doses of haloperidol attenuate

amphetamine-induced CPP (Hawkins & Stein, 1991; Spyraki, Fibiger, &
Phillips, 1982b; Wise & Rompre, 1989). Furthermore, lesions to DA
neurons in the NA blocks cocaine self-administration, but not cocaine-

induced CPP (Dworkin, Guerin, Goeders, & Smith, 1988; Spyraki, Fibiger,
& Phillips, 1982b).

In summary, CPP is an excellent paradigm for evaluating reward

processes (Bozarth, 1987; Schecter & Calcagnetti, 1993). Drugs that
increase DA levels, such as cocaine and amphetamine, induce the
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acquisition and expression of GPP. Antagonists of either the Pi or the Da
receptor attenuate the acquisition of CPP, but only Di receptor

antagonists attenuate the expression of CPP (Hawkins & Stein, 1991; Hiroi
& White, 1991a; Leone & DiChiara, 1987; Reicher & Holman, 1977;

Sherman et al., 1980; Spyraki, Fibiger, & Phillips, 1982a; Spyraki, Fibiger,

& Phillips, 1982b; Wise & Rompre, 1989). Thus, two dissociable processes
(i.e., acquisition and expression) are important for place preference
conditioning; however, it appears that both of these processes are
mediated by dissociable DA systems.
OPIOID REWARD

Operant conditioning and CPP studies also indicate the presence of
a mesolimbic opioid system. Research indicates that a tonically active

endogenous opioid system modulates the basal activity of mesolimbic
DA neurons and, in this way, the opioid system has a marked effect on

conditioned behaviors. Opiate-induced reward can be attenuated by DA

receptor antagonists such as SCH 23390 and eticlopride, as well as the

opioid antagonists naloxone and naltrindole (Bozarth, 1987; Bozarth &
Wise; 1981; Hawkins & Stein, 1991; Phillips et al., 1991).
Operant Conditioning Studies

The operant conditioning paradigm has provided evidence that

opioid receptors have a role in DA reward processes. The reinforced
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respGnding induced by morphine self-administration increases DA within
the NA (Shippenberg et al., 1993). Moreover, recent electrochemical
techniques suggest that p-opioid activation within the VTA results in a
dose-dependent increase in DA electrochemical signaling (Noel &
Gratton, 1995).

The infusion of morphine directly into the VTA causes rats to selfadminister increasing doses of the drug, as evidenced by a more rapid

bar-pressing rate (Olds, 1992). This illustrates that the rewarding
properties of morphine, as reflected in increased self-administration
behayior, are due to activation of DA neurons in the VTA (Bozarth,

1987). Additionally, Rompre and Wise (1988) demonstrated specifically

that A10 VTA DA neurons are activated by morphine. They implanted
electrodes that allowed rats to self-administer electrical stimulation to

AlO neurons. Systemically injected pimozide increased the threshold for
self-stimulation, while morphine injected into the VTA reversed the

effects of pimozide, causing animals to revert back to the previous

pattern of self-stimulation. Naloxone blocked the reversal effects of
morphine and the GABA agonist muscimol reinstated self-stimulation
behavior, apparently because rats were motivated to increase morphine

reinforcement (Rompre & Wise, 1988). This operant conditioning study
again indicates that DA cells in the VTA are important for reward and
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suggests that DA is involved in morphine^nduced reward. The study also

points to the role GABA receptors play m niorphine-induced reward by
demonstrating that a GABA agonist can block morpliine's actions
(Rompre & Wise, 1988).
CPP

GPP studies also show that the endogenous opioid system is

involved in reward. CPP can be induced by injecting D-ala-met

enkephalin (a specific p. receptor agonist) directly into the VTA.
Importantly, microdialysis has shown that this causes a concurrent
increase in extracellular DA within the NA. Pretreatment with an opiate

antagonist, such as naloxone or naltrindole, attenuates opiate-induced
CPP, while at the same time suppressing DA levels in the NA (Barr & Rossi,
1992; Bozarth & Wise, 1980; DiChiara & North, 1992; Hawkins & Stein,
1991; Suzuki, Tsuji, Mori, & Misawa, 1995). This implicates the

endogenous opioid system in reward and suggests that it is located
within the VTA. k opioid subtypes are also involved in reward, since

activation of k opioid receptors attenuates responding for morphine
(Mucha & Herz, 1985; Suzuki et al., 1995). Specifically, pretreatment
with the k agonist U-50,488H blocks the normal accumulation of

morphine-induced DA in the NA, while completely abolishing morphineinduced CPP (Mucha & Herz, 1985). When taken together, these studies
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indicate that stimulation of |i receptors activates DA neurons, while k
receptor stimulation inhibits DA neurotransmission.
In summary, examination of the neurochemical mechanisms of
reward indicates that an endogenous DA reward system mediates the

rewarding properties of food and water. The endogenous opioids are also
involved in reward, apparently by activating the DA reward system.

Instrumental conditioning, operant conditioning and CPP studies have
shown that both an endogenous DA and opioid system are components
of the reward pathway.
SEROTONIN STRUCTURE AND FUNCTION

Surprisingly, evidence supports the concept that the reward system
can be modified by experimental changes in serotonin neurotransmisson

(Bilsky & Reid, 1991; Carboni, Acquas, Frau, & DiChiara, 1989; Carboni,
Acquas, Leone, Perezzani, & DiChiara, 1988; Higgins, Joharchi, Nguyen, &
Sellars, 1992; Imperato & Angelluci, 1989). Therefore, an examination of
serotonin neurobiology will be followed by studies assessing interactions
between DA and serotonin systems within the reward process.
Serotonin

Pathwavs

The connections made by serotonin neuronal processes throughout

the brain indicates its potential to modulate DA neurotransmission.
Serotonin axons innervate many of the same regions of the CNS where DA
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pathways are found (Jacobs & Azmitia, 1992). Passing through the
medial forebrain bundleV serotonin pfojections reach tnany rostral sites

including the striatum, limbic structures, diencephalon and the cerebral
cortex (Jacobs & Azmita, 1992; Shizgal <& Murray, 1989) (see Figure 6 and

1). ■ . ;

/

''

Although outnumbering noradrenergic and DA cells, serotonin cell
bodies are localized to a few nuclei in the brain stem (Lauder & Bloom,

1975). Serotonergic neurons arise from distinct nuclei called the dorsal

raphe and median raphe. Raphe nuclei lay directly along the midline of
the brainstem from the medulla to the midbrain and their fibers have

both ascending and descending pathways (Lauder & Bloom, 1975;
Nicholls et al., 1992; Steinbusch, 1984). Projecting to the medulla,

descending fibers are believed to modulute spinal sensory and motor
neurons, and are involved in regulating motor movenients as well as in

the perception of pain (Parent, Descarries; & Beaudet, 1981). This
apparently is the reason that application of a serotonin agonist causes
excitability of motor pathways.

Studies of ascending fibers indicate tbat raphe nuclei in the pons
and midbrain innervate the entire brain, projecting from the locus

coerleus to forrn part of the ascending reticular activating system.
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Figure 7 Serotonin Pathways: Lateral View.
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Thus, 5-HT neurons have been implieated Tn the sleep-wake cycle,
through the naodulation of locus coerleus functioning and possibly other
unknown rnechanisnis (Steinbusch, 1984).

The intraventricular administration of the serotonin ttacer i3H]-5i
hydroxytryptamine shows that ascending serotonin axons pass next to

DA neurons (Parent ef aLy 1981). Sirnilarly^ serotonin-like cells and fibers
are found in close proximity to AlO DA neurons in the VTA, indicating
that mesolimbic DA neurons within the AlO area of the tegmentum

appear to be innervated by serotonergic axons projecting from thp
pontine raphe (Halliday & Tork, 1989) (see Figure 8);
Serotonin Receptors: Distribution And Function

Researchers have attempted to detail the distribution of serotonin

receptors through assays of genetic material immunoreactiye analysis
and radiographic bindihg studies. Serotonin mRNA has been found in the
NA, striatum, tegmentum, spinal cord, baSal forebrain, nucleus basalis,

olfactory tubdrcle and Cerebral cortex (Johnson & Heineniann, 1995).
Released from the terminal, serotonin neurotransmitter binds to its

receptor binding site (see Figure 9).
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Serotonin receptors are grouped into three basic families according
to structure and second messenger system properties: 1) the 5-HTi family
includes 5-HTia, 5-HTid, 5-HTie and 5-HTif, which utilize G-protein

mediated signal transduction; 2) the S-HTi family includes 5-HT2a, 5
HT2B. 5-HT2C and 5-HT4, which use phosphoinositol-mediated signal
transduction; 3) the 5-HT3 receptor which controls an ion-gated channel

for signal transduction (Dubovsky & Thomas, 1995) (see Figure 10).

Specifically, somatodendritic serotonergic autoreceptors of mainly the 5
HTia type are found on serotonin neurons in the raphe nucleus ^nd
function to modulate firing of serotonergic neurons (Jacobs & Azmitia,
1992).

Autoreceptors located on terminals are of the 5-HTid variety, and

they modulate release of neurotransmitter from serotonergic terminals
(BoeSs & Martin, 1994). Serotonin receptors located in the mesolimbic
area include the 5-HTiA and 5-HT3 subtypes (Barnes, Barnes, Costall,

Ironside, & Naylor, 1989; Boess & Martin, 1994; Jacobs & Azmitia, 1992).
Evidence implicates 5-HT3 receptors in a presynaptic role, both in
the peripheral nervous system (PNS) and the central nervous system

(CNS). Besides being localized to presynaptic sites on fibers and terminals
in the PNS, research suggests that the 5-HT3 receptors are also located on

axons at synaptic terminals in regions of the mesolimbip^ nueleus tractus
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solitarius, and medulla dhlongota (Barnes, Bames, Costall, Ironside, &

Naylor, 1989; Kidd et al., 1993; Lapdrte et al., 1992). Impdrtantly,
autdradidgraphic studies have fdund that 5-HT3 receptdrs appear td

reside dn fibers which prdject frdm serdtdhin cell bddies clustered in

raphe nuclei. These fibers appear td pass near DA cells located in the
midbrain (Barnes, Barnes, Cdstall, Ironside, & Naylor, 1989; Kidd et al.,

1993) (see Figure 1). Biochemical, electrophysidldgical and behavioral
studies indicate that 5-HT3 ;reCeptdrs modulate the release of DA,

serotonin, norepinephrine, acetylchdline and cholecystokinin (Barnes,
Barnes, Costall, Naylor, & Tyers, 1989; Blandina, Goldfarb, CraddockRoyal, & Green, 1989; Grant, 1995).

The; highest density of 5-Ht3 mRNA sequences and receptor binding
is found in the nucleus tractus solitarius, dorsal motor nucleus of the

vagus nerve, area postrema, spinal tract of the trigeminal nerve, and on
all parts of the medulla oblongota (Cohen, T990; Kilpatrick, Jones, &
Tyers, 1988).

PCR amplification of mRNA 5-HT3 sequences also indicates the

presence of the 5-HT3 receptor in the rat NA and VTA, and transcripts
were detected in mouse embryo tegmentum as early as day 14 of

gestation (Johnson & Heinemann, 1995; Maricq, Peterson, Brake, Myers, &
Julius, 1991). Autoradiographic studies of the mesolimbic region appear
42

to confirm the presence of 5-HT3 receptors in the NA and VTA. However,

they are most dense in entorhinal cortex, hippocampus and amygdala,
where it is believed that they exert their effects on cognition, anxiety,

depression, psychotic symptoms, arid the expression of reward (Boess &
Martin, 1994; Hiroi «& White, 1991b; Johnson & Heinemann, 1995; Maricq
et al., 1991).

In summary, autoradiographic and mRNA evidence supports the

close proximity of 5-HT3 receptors to the DA reward pathway. Its
presynaptic location and ligand-gating properties suggests a functional
role in neurotransmitter release. Because this receptor is found both

peripherally and in many regions of brain, systemic injection of 5-HT3
agonists and antagonists have the potential of affecting not only the
mesolimbic system but other systems as well.
DA AND SEROTONIN INTERACTIONS

Evidence supports the concept that serotonin receptors are

important in rnodulating DA levels and release characteristics within the
mesolimbic system (Carboni, Acquas, Frau, & DiChiara, 1989; Costall et
al., 1976). When a serotonin agonist is given systeinically, measurable
increases of DA occur in the NA (Blandina et al., 1989; Blandina,

Goldfarb, & Green, 1988; Jiang, Ashby, Kasser, & Wang, 1990; Yi, Gifford,
& Johnson, 1991). In cbntrast, systemically injected 5-HT3 antagonists
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attenuate DA and serotonin agonist-induced increases of DA in the NA

(Costall, Hui, & Naylor,1979; Hagan et al., 1987; Imperato et al., 1992).
Conversely, DA levels appear to regulate serotonin release.

Serotonergic projections extending from serotonin cell bodies in the

raphe nuclei, pass near dopaminergic cells clustered in the- A10 region of
the mesolimbic system. These serotonergic cells respond to changes in DA

levels by adjusting the amounts of serotonin neurotransmitter they
release (Barnes, Barnes, Costall, Ironside, & Naylor, 1989; Kandel et al.,
1995; Kidd et al., 1993). Thus, the amount of DA in the VTA appears to

be important in regulating serotonin production and release and, in
turn, serotonin appears to regulate DA levels (Costall et al, 1987; Perry,
Kostrzewa, & Fuller, 1995).

Experimentation on one of the earliest 5-HT3 antagonists
demonstrated that it produced inhibiting effects on DA agonist-induced
reward behaviors in rats (Costall et al., 1987). Called ondansetron, this 5

HT3 receptor antagonist inhibits amphetamine-induced locomotor

activity. The attenuation of DA activation was achieved only when the
5-HT3 antagonist was injected systemically or directly into the VTA and
had no effect when localized injections were applied directly to the NA

(Costall et al., 1979; Imperato & Angelucci, 1989). These studies caused

heightened interest in the 5-HT3 receptor and created a proliferation of
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research on the role of 5-HT3 receptors in modulating DA
neurotransmission and reward (Acquas, Carboni, Grarau, & DiChiara,

1990; Bilsky & Reid 1991; Carboni, Acquas, Frau, & DiChiara, 1989;
Carboni, Acquas, Leone, & DiChiara, 1989; Suzuki et al., 1992).
DA and Serotonin Interaction: Receptors

Evidence suggests that the serotonin receptor has a vital role in

modulating DA functioning in the mesolimbic system. Serotonin agonists
activate DA neurons in the VTA, resulting in increased DA within the NA,

whereas antagonists attenuate these agonist-induced increases (Costall et
al., 1987; Imperato & Angelucci, 1989; Invernizzi et al., 1995). Although

serotonin antagonists attenuate the enhanced DA levels produced by DA
and serotonin agonists, these antagonists have no effect on basal levels of
DA (Costall et al., 1987; Invernizzi et al., 1995). This implies that
serotonin functions in a "homeostasis-like" role to regulate DA levels in

the mesolimbic system (Carboni, Acquas, Frau, & DiChiara, 1989; Costall
et al., 1987; Imperato & Angelucci, 1989; Invernizzi et al., 1995; Pel,
Zetterstrom, Leslie, & Grahame-Smith, 1993).

Cellular studies confirm the impact that 5-HT3 agonists and

antagonists have on the DA neuron. When applied to brain slices
containing DA cells, the 5-HT3 agonist 2-methylserotonin causes
increased DA release that is blocked by the 5-HT3 antagonist tropisetron

45"

(Blandina et al., 1988, 1989). Although, 5-HT3 agonists increase DA
release, and 5-HT3 antagonists block release, the mechanisms mediating
these effects remain uncertain (Carboni, Acquas, Frau, & DiChiara, 1989;

Costall et al., 1976; Gifford & Wang, 1994; Imperato & Angelucci, 1989).
There are several possibilities: that 5-HT3 drugs affect the DA transporter

system, that 5-HT3 receptors modulate DA neurons through receptors
located near GABAergic interneufons, or that 5-HT3 drugs directly bind to
5-HT3 receptors located on DA terminals, which act to modulate DA
release (Boess & Martin, 1994; Costall & Naylor, 1992; Klein et al., 1993;
Yi et al., 1991).

First, evidence indicates that serotonin agonists may affect DA

levels by binding to serotonin receptors, resulting in the modulation of
the reuptake of DA into the presynaptic neuron. There is also an

implication that 5-HT3 receptors may block DA reuptake (Yi et al., 1991)
(see Figure 11).

Although binding studies demonstrate the presence of 5-HT3

receptors in the striatum and NA, direct injections of serotonin

antagonists into these regions have no effect on DA content (Imperato &
Angelucci, 1989; Yi et al., 1991). When a 5-HT3 receptor agonist is applied
to rat striatal cells, it induces DA release in synaptosomes, as well as a
Ca++-evoked efflux.
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Reuptake

Both of these effects can be antagonized by the selective DA uptake
inhibitors nomifensine and cocaine. This implies that serotonin induces

the release of DA from striatal cells by modulating DA reuptake into the

DA terminal (Yi et al., 1991). Curiously, when a 5-HT3 antagonist is

applied to striatal cells, or is locally injected into striatum, there is no
attenuation in the DA release produced by 5-HT3 agonists (Costal et al.,

1987; Yi et al., 1991). This suggests that action on the DA reuptake

transporter may not be responsible for the actions of these serotonin
drugs (see Figure 12).

Second, the possibility remains that 5-HT3 antagonists affect DA

release by modulating GABA interneurons located in the VTA (Klein et
al., 1993) (see Figure 13). For instance, Imperato and Angelucci (1989)
demonstrated that the direct perfusion of 5-HT3 antagonists into the NA

had no effect on morphine's actions. To attenuate this drug-induced
increase in DA, 5-HT3 antagonists must be injected systemically or

directly into the VTA where GABA interneurons can affect DA release
(Imperato & Angelucci, 1989; Roth, 1994).

The third possibility is that activation of 5-HT3 receptors, perhaps
located on DA processes, may directly modulate DA release. mRNA and

autoradiography studies suggest that 5^HT3 receptors are present in both
the NA and VTA.
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Therefore, the possibility exists that S-HTj agonists or antagonists

are capable of directly affecting DA release by modulating presynaptic or

postsynaptic sites on dopamine processes (Boess & Martin, 1994; Carboni,

Acquas, Leone, & DiChiara, 19S9; Leone & DiChiara, 1987; Roth, 1994; Yi
et aL, 1991).

If it is the 5-HT3 receptor that is directly affected by 5-HT3 drugs,

then two questions still remain: 1) do these receptors reside on serotonin
terminals projecting into the VTA or the NA, or 2) do other neurons or

their processes contain these 5-HT3 receptors. Serotonin antagonists and
addictive drugs are being used to resolve these questions. They are

capable of dissociating the mechanisms of the DA reward system.
However, much remains to be learned. Although the rewarding effects of

cocaine can be attenuated by 5-HT3 ahtagonists, the receptor

mechanisms responsible for this antagonism appear to be different than
for other addictive drugs (Di Chiara & North, 1992). Microdialysis studies

have suggested that while serotonin ahtagonists inhibit cocaine-induced
CPP, DA levels remain unchanged in the NA (Svingos et al., 1991), Some

believe that the serotonin antagonist's affinity for binding with 5-HT

receptors may simply allow them to competitively displace cocaine.
Successful attenuation by 5-HT3 antagonism of cocaine-induced CPP can

be accomplished when 10-fold doses are used, yet DA content remains

: 5.1

unchanged in the NA. This implies cocaine's actions may be mediated by
other brain regions (Gifford & Wang, 1994; Paris & Cunningham, 1993;
Peltier & Schenk, 1991).

Cellular studies have produced a different understanding of
cocaine's action on the 5-HT receptor. Utilizing patch-clamp techniques

on nodose ganglion cells, evidence demonstrates that the application of
5-HT (5-hydroxytryptamine) produces a fast inward current. When the 5

HTs antagonist MDL-72222 is pre-applied to the tissue, a blockade of this
inward current is observed (Fan, Visentin, & Weight, 1994). The selective

5-HT3 agonist 2-methyl-5-HT reinstates this inward current. When
cocaine alone is applied, it has no effect on membrane current, but if
cocaine and 5-HT are applied together, the serotonin-induced peak and

steady-state current are reduced. If cocaine is pre-applied to the tissue
before the 5-HT agonist, the peak and steady-state current is further

depressed by cocaine. This suggests that cocaine inhibits 5-HT3 receptormediated inward current (Fan et al., 1994; Lambert et al., 1989; Vanner

& Surprenant, 1990). It also implies that some of cocaine's action may
result from its competitive antagonism of 5-HT3 receptors, resulting in a
blockade of serotonin action.

In contrast to cocaine studies, experimental research has provided

a clear understanding of the mechanisms in 5-HT3 receptor antagonism
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of morphine-induced reward. The prerequisite for the expression of
morphine reward is the stimulation of DA release in the NA. Therefore, if
5-HT3 antagonists can suppress drug-induced increases in DA, it supports
a role for the serotonin receptor in the expression of the reward system

(Imperato & AngeluCci, 1989). Systemic injections of many 5-HT3
antagonists, such as MDL-72222, ICS205-930 and ondansetron, cause a

full or partial blockade of mOrphine-induced DA release in the NA
(Carboni, Acquas, Leone, & DiChiara, 1989; Imperato & Angelucci, 1989;

Pei et al., 1993). Similarly, direct injections into the VTA of ICS205-930,
causes a reversal of the morphine-induced DA release in the NA
(Imperato & Angelucci, 1989).

In summary, although evidence suggests that many 5-HT3 agonists
increase DA release in the NA (an action blocked by 5-HT3 antagonists)

the exact receptors mediating the DA/serotonin interactions remain
uncertain (Carboni, Acquas, Frau, & DiChiara, 1989; Costall et al., 1976,
Gifford & Wang, 1994; Imperato & Angelucci, 1989). Research has also
shown that 5-HT3 receptor antagonists are capable of attenuating

morphine- and cocaine-induCed reward (Carboni, Acquas, Leone, &
DiChiara, 1989; Imperato & Angelucci, 1989; Pei et al., 1993).
DA and Semtnnin Interaction: Rat Behavior

Behavioral studies utilizing injections of serotonin agonists and
. . ■ 5 3- '

antagonists have resulted in a greater understanding of the serotonin
receptor's role in the DA reward pathway (Carboni, Acquas, Leone, &
DiChiara, 1989, Carboni, Acquas, Frau, & DiChiara, 1989; Imperato &

Angelucci, 1989; Suzuki et al., 1992). However, little is known about the
involvement of serotonin receptors in the expression of reward.

Most

studies have tested only the acquisition of reinforced behavior (Acquas et

al., 1990; Carboni et al., 1988; Higgens et al., 1992; Pei et al., 1993).

Overall, acquisition of cocaine- and morphine-induced conditioned
behaviors is blocked by antagonists of the S-HTg receptor, while these

antagonists fail to affect cocaine self-administration and stimulus
discrimination (Borg & Taylor 1994; Culcagnetti et al., 1995, Curbpni et

al, 1988; Higgins et al.,/ 1992; Joharchi et al., 1993; Martellota et aL,
1994; Pei et al, 1993; Svingos & Hitzemanh- 1992). For example, systeinic

injection of S-HTs antagbnists decrease cocaine-induced locomotion
(Reith, 1990; Svingos & Hitzemann, 1992). Acquisition of cocaine-induced
CPP was also attenuated by systemic treatment with 5-HT3 antagonists

(Suzuki et al, 1992; Svingos & Hitzemann, 1992). In contrast, S-HT^

antagonists only appear to block the locomotor activity produced by
chronic, but not acute, cocaine treatment (King et al., 1994).

Along with blockihg many cocaine-induced behaviors, 5-HT3

antagonists attenuate morphine-induced responses in rats (Acquas et al.,
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1990; Bilsky & Reid, 1991; Borg & Taylor 1994; Carboni et al., 1988;
Higgins et al., 1992; Joharchi at al., 1993; Pel et al., 1993; Suzuki et al.,
1992). S-HTs antagonists not only inhibit certain conditioned behaviors,

they attenuate morphine-induced DA increases in the NA. Consistent
with this finding, S-HTs antagonists attenuate morphine-induced CP?
and locomotion (Carboni et al., 1988; Higgins et al., 1992; Pei et al.,

1993). Interestingly, MDL-72222 and ondansetron were unable to block

morphine self-administration (similar results were obtained with
cocaine) (Borg & Taylor, 1994; Higgins et al., 1992). This suggests that

regional specificity of drug effects may be involved in different behaviors
(Svingos & Hitzemann, 1992).

In summary, studies examining the biochemical and behavioral
actions of addictive drugs demonstrate that they produce reward by

activating the mesolimbic DA system. The blockade of morphine- and
cOcaine-induced reward by antagonists of the S-HTj receptor, clearly

imply that this receptor is involved in the expression of reward. In
addition, evidence has suggested that the biochemical consequences of 5

HT3 antagonism is the inhibition of DA release in the NA. Thus, the
antagonism of drug-induced reward behavior can be utilized to
demonstrate the role of the 5-HT3 receptor complex in mesolimbic
reward.
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DEVELOPMENTAL MPUCAHONS

Ontogeny of Neurotransmitter Systems: DA
Although the behayioral responses inay yary from those of the

adult, it is apparent that Di and D2 receptor actiyation has behayioral
effects in preweanling rats. Receptor binding studies suggest that both Di

and D2 subtypes are present at birth and maintain a 1:1 ratio until 15

days postnatally (Gelbard, Teicher, Faedda, & Baldessarini, 1989; Giorgi
et al., 1987; Sales, Martres, Bouthenet, & Schwartz, 1989). After this

period, Di receptors begin to outnumber D2receptors,with an adult-like
ratio occurring by about 60 days of age (Gelbard et al., 1989; Murrin &
Zeng, 1986; Zeng, Hyttel, & Murrin, 1988). While the exact deyelopmental
implications of this disparity remains uncertain, some behayioral
differences haye been determined using psychopharmacological
eyidence.

Behayioral studies indicate that selectiye DA receptor agonists

produce age-dependent behayioral differences in rats. For example, adult
rats injected with the Di agonist SKF-38393 or the D2 agonist quinpirole

respond with increased grooming or yertical behayior, respectiyely
(Moody & Spear, 1992). In contrast, rat pups giyen injections of SKF
38393 or quinpirole exhibit increased forward locomotion and/or sniffing
behayior, while the typical adult behayiors are absent (Moody & Spear,
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1992). Similarly, when rat pups under 17 days old are pretreated with
the irreversible DA antagonist N-ethoxyGarbohyl-2-ethoxy-l,2

dihydroquinoline (EEDQ), the response to DA agonists differs from that of
the adult rat. Unlike adults, rat pups fail to exhibit the attenuation of

stereotyped behaviors induced by the nonselective agonist R

propylnorapomorphine (NPA) (McDougall & Bolanos, 1995; McDougall,
Crawford, & Nonneman, 1992; Mestlin & McDougall, 1993). In addition,

preweanling rats, when compared to adultsv show a greater behavioral

response tO psychomotor stimulants like cocaine (Spear & Brick, 1979).
In spite of these ontOgenetic differences, evidence suggests the

presence of functional Di and D2 receptors in preweanling rats (Moody &
Spear, 1992). Nonetheless, it is important to understand the ontogenetic
behavioral differences that can be elicited by different combinations of

Di, D2 or D1/D2 receptor agonist stimulation.

Ontogeny of Neurotransmitter Systems: Opiates
Evidence indicates that rats as young as 5 days old have

functional opioid receptors and possess the ability to respond

behaviorally to opiate drugs (Kehoe & Blass, 1986). Binding studies
demonstrate that opiate receptors are present and functional 15 days

following birth (Bayon, Shoemaker, Bloom, Mauss, & Guillemin, 1979;
Khachaturian, Alessi, Munfakh, & Watson, 1983).
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Pharmacological responding can also be an indicator of neonatal

opiate receptor maturity. Potential maturity can be assessed by
measuring the, ability of rat pups to exhibit morphine-induced CPP (Barr
& Rossi, 1992). When a morphine dose, corresponding to the lowest
effective adult dose, is injected directly into the VTA of 4-day-old rats,
CPP is established. As in adult rats, only localized injections into the

VTA, and not the NA or other brain areas, produces CPP in rat pups (Barr

& Rossi, 1992). This implies that the neonatal reward system is

functional shortly after birth and that opiate reward depends upon VTA
activation (Laviola et al., 1992; Moran et al., 1981; Phillips & LePiane,
1980).

Although adult and preweanling rats exhibit morphine-induced
reward, evidence suggests that drug-induced motor behaviors vary

considerably (Caza & Spear, 1980). Specifically, a high (5.0 mg/kg) dose

of morphine causes a decrease in locomotion and a low (1.0 mg/kg) dose
increases locomotor activity in preweanling rats, In contrast, rats older

than 17 days exhibit a reversal of this behavioral pattern (Caza & Spear,

1980; Spear & Brake, 1983). Importantly, morphine produces CPP in rats
as young as 4 days of age (Barr & Rossi, 1992).
Importantly, CPP, as evidenced by time spent in the morphine
conditioned environment, can be induced through localized VTA or
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systemic injections shortly after birth (Barr & Rossi, 1992). Evidence
indicates that rats have functional opiate receptors early in the

preweanling period and are capable of performing morphine-induced
CPP in a manner similar to adults (Barr & Rossi, 1992; Bayon, Shoemaker,

Bloom, Mauss, & Guillemin, 1979; Khachaturian et al., 1983; Laviola et
al., 1992; Pruitt et al., 1995).
Ontogeny of Neurotransmitter Svstems: Serotonin

There is little research assessing the ability of serotonin antagonists

to block DA agonist-induced behavior or neurochemical effects in
neonatal rats (Pranzatelli, 1992). However, available evidence supports

the concept that serotonin is present early in the prenatal period and
that some receptor subtypes are functiorial at birth (Pranzatelli, 1992;
Pranzatelli, Durkin, & Barkai, 1994). Research suggests that one of the
first neurochemical systems to differentiate during ontogeny is serotonin.
In the rat, serotonin neurons develop by day 13 of gestation and the

serotonin neurotransmitter system becomes functional near the end of

term (Eaton, Staley, Mordecai, GlobUs, «& Whittemore, 1995; WhitakerAzmitia, 1991). Research also suggests that serotonin is synthesized by

raphe fetal cells and performs specific functions early in gestation.
Serotonin may actually be produced before synaptic processes are
needed, as evidenced by the fact that the fetus has serotonergic neurons
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containing enzymatic material well, before there is synaptic contact
made at the terminal level. This suggests that serotonin may actually be

synthesized and released within cells of the CNS to function in
developmental processes (Eaton et al., 1995; WhitakerrAzmitiaj, 1991). For
example, serotonin may guide the development of its own neurons

(Eaton et al., 1995) and instigate and control neurite growth (WhitakerAzmitia, 1991).

Receptor binding studies demonstrate the presence of serotonin

receptors in rat pups and pharmacological research suggests functional

responsiveness shortly after birth (Daval et al., 1987; H^d & Engel, 1988,
Johansson-Wallsten et al., 1993; Pranzatelli et al., 1992, 1994). Utilizing

tracer and radiographic techniques, it was found that the 5-HTiaj 5-HT2
and 5-HTic serotonin subtypes are present at birth (Daval et al., 1987).
Serotonin receptor systems are capable of mediating behavior in
neonatal rats. For example, rat pups have an increased sensitivity to the

5-HTia receptor agonist 8-OH-DPAT, as indicated by rapid involuntary

muscle jerks and an increase in myoclonus. This is what one would

expect from a compensatory serotonin (5-HTia) supersensitivity or
increased receptor density from repeated exposure (Ashby, Zhang,

Edwards, & Wang, 1994; Hard & Engel, 1988; Pranzatelli et al., 1992,
1994). However, studies directly measuring preweanling rat sensitivity
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and responsiveness to 5-HT3 agonists or antagonists are nonexistent
(Boess & Martin, 1994; Johansson-Wallsten, Berg, & Meyerson, 1993).

Nonetheless, evidence suggests that 5-HT3 receptors are present shortly
after birth, and that the ability of neonates to respond behaviorally to

other serotonin agonists is also present a few days following birth
(Johansson-Wallsten et al., 1993). For example, serotonin agonists DOI, 8
OH-DPAT and fenfluramine are capable of inducing

psychopharmacological responsiveness from birth to periadolescence,
and no discontinuities in behavior have been observed (Hard & Engel,
1988; Johansson-Wallsten et al., 1993; Spear & Brake, 1983).
In summary, research suggests that preweanling rats possess
functional DA, opiate and serotonin receptors, providing them with the
ability to develop morphine- and cocaine-induced CPP. It is uncertain,

however, whether serotonin receptor antagonism is capable of disrupting
morphine- and cocaine-induced CPP in preweanling rats. Such a
disruption occurs in adult rats, but the effects of serotonin antagonism
on reward have not yet been assessed during the preweanling period.
GENERALPURPOSE AND HYPOTHESIS

Many drugs of abuse share the common ability to increase

extracellular DA levels in the mesolimbic system. It has been suggested
that this may actually be the source of their rewarding properties
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(DiChiara & Imperato, 1988). More specifically, the neuronal

consequences of cocaine and morphine involve their ability to increase
extracellular DA levels within the mesolimbic DA terminal regions,

presumably due to the excitation of A10 DA neurons in the VTA (Gysling
& Wang, 1983; Leone & DiChiara, 1987). The behavioral consequences of
cocaine and morphine involve their ability to induce a state of reward
which can be assessed via the CPP paradigm (Bozarth, 1987; Carboni,

Acquas, Leone, & DiChiara, 1989; Higgens et al., 1992). In adult rats,
acquisition of cocaine- and morphine-induced CPP can be blocked by

prior treatment with the S-HTs antagonist MDL-72222. To date, it is
unknown whether MpL-72222 will block the expression of cocaine and

morphine CPP. MDL-72222 appears to exert its inhibitory effects on

reward functioning by its ability to ultimately decrease DA release in the
NA (Acquas et al., 1990; Bilsky & Reid, 1991; Carboni, Acquas, Frau, &

DiChiara, 1989; Carboni, Acquas, Leone, & DiChiara, 1089; Suzuki et al.,

1992). Unfortunately, it is not known in which brain afea these critical

5-HT3 receptors are located. Moreover, it has not yet been determined
whether 5-HT3 antagonists are capable of modulating the acquisition
and expression of cocaine- and morphine-induced reward in the
preweanling rat.

Therefore, the purpose of this study is two-fold: first, to determine

whether systemically injected MDL-72222 (a 5-HT3 antagonist) will block

the expression of a previously established cocaine- or morphine-induced
CPP in preweanling rats. Second, if MDL-72222 does not block the

expression of CPP then we will determine whether systemically injected
MDL-72222 is capable of attenuating the acquisition of cocaine- or
morphine-induced CPP in preweanling rats.
The exact hypotheses are as follows. (1) Both morphine and

cocaine are hypothesized to produce CPP in preweanling rats. (2)

Systemic treatment with a full dose range of MDL-72222 is predicted to
block the expression of morphine- and cqcaine-induced CPP. If

systemically injected MDL-72222 does not affect the expression of CPP
(see hypothesis 2) then I will assess whether MDL-72222 blocks the
acquisition of CPP. (4) It is hypothesized that a full dose range of MDL
72222 will attenuate the acquisition of morphine- and cocaine-induced
CPP.
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mMlMENTl
Method

Siihjects. Subjects were 122 Cn==7-ll) male and female rats of

Sprague-Dawley descent {Harlan Industries/ Indianapolis, IN, USA). The
rats were bred and raised at California State University, San Bernardino.

Litters were culled to a maximum of 10 pups at 3 days of age. The

colony room was maintained at 20-230 C and kept under a 12:12 h
lightrdark cycle. Rats were tested when 17-19 days old.
Apparatus. The testing apparatus was a rectangular plywood
chamber that has three compartments separated by removable

partitions. The two end compartments measure 15 X 15 X 21 cm high,
while the middle compartment measures 9 X 15 X 21 cm high. All

compartments are painted gray and are covered by a clear Plexiglas top.
One end compartment has rubberized non-slip flooring, whereas the
other end compartment has plywood flooring scored (1 cm deep) in a
checkerboard fashion. The middle compartment has smooth plywood

flooring. Besides the tactile differences, both end compartments are

equipped with an odor delivery system. More specifically, beneath each
end compartment, and connected via 15 small holes in the floor, are

rectangular plastic containers (14 X 7 X 4 cm high) partially filled with
pinewood chip bedding. Lemon and almond extracts are applied to the
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pinewood bedding of each container to provide distinctive odor cues for
the end compartments (10 cc of the extract is used for conditioning and
1 cc is used for preference testing). During conditioning, solid partitions

are used to keep rats in the appropriate compartments, whereas during

testing the partitions are raised 5.5 cm so that each rat can move freely
between

the

compartments.

Procedure and Drugs. Rat pups were given two 30 min

conditioning trials on each of the two consecutive days. On the first
conditioning day, the rats were given one saline injection and placed in
a novel scented compartment for 30 min. This was repeated 4 hours
later. On the second day, the rat pups were injected i.p. with saline,

cocaine (20 mg/kg), or morphine (0.5 mg/kg), placed in a chamber for
30 min, and presented with a novel odor. The identical procedure was

repeated four hours later. Importantly, drug treatment and chamber
scent (lemon or almond) were counter-balanced so that scent alone
would not confound results.

Following the two days of CPP conditioning, rat pups were injected
with saline or the selective serotonin 5-HT3 receptor antagonist MDL

72222. Thirty minutes later rats were given free access to both scented
chambers for 15 min. It was predicted that MDL-72222 would block the

expression of the cocaine- and morphine-induced place preference (see
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Figure 14 for a summary of this experiment).
Data Analysis. Both conditioning sessions and testing sessions were

video taped for behavioral assessment by a rater blind to treatment
conditions. Total time spent in each compartment was measured in
each treatment and control condition. Total time spent in the drug-

paired compartment and locomotor activity (line-crosses) was analyzed
using t-tests and analyses of variance (ANOVAs). Significant main effects
and interactions were analyzed using Tukey tests.
Research Setting. Behavioral assessment was doiie in the vivarium.
Results

T.ocomotor

Activitv. The mean locomotor activity counts of

morphine-, cocaine-, and saline-treated rats during conditioning are
shown in Figure 15. Overall, cocaine-treated rats had significantly more
line-crosses than saline- or morphine-treated rats, F (2,116)= 80.54, P. <
.05.

rnnditionerl Plaee Preference. MDL-72222 (0.17, 0.5, 1.5, 4.5 mg/kg,

IP) failed to significantly block the expression of either morphine- or
cocaine-induced CPP in 17-day-old rats (see Figures 16 and 17). More

specifically, test day treatment with MDL-72222 did not affect the

compartment preference of morphine- or cocaine-treated rats, F(4,40)=
1.40, P>.05; F(4,37)= .405, P>.05; respectively.
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EXPRESSION EXPERIMENT

Systemic Injections
{MDL72222 Given Post-conditioning)
Drugs

MDL72222

MDL72222

MDL72222

MDL72222

0-17 mg/kg . t.5 mg/kg
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'o.'o mg/kg

o.'5 mg/kg

4.5 mg/kg

i.p.

i.p.

.i-P-

i.p.

i.p.

Coc 20.0

mg/kg i.p.
Morph 0.5

mg/kg i.p.

Saline i.p.

^ Protocol Design of Expression Experiment.
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LOCOMOTOR ACTIVITY
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Figure 15, Mean number (+SEM) of line-crosses in the drug-paired
companment of the CPP apparatus during both conditioning sessions (30
nun each). The 17-day-old rat pups were injected with cocaine (20.0

mg/kg, IP), morphine (0.5 mg/kg. IP), or saline immediately prior to
conditioning (n=7-ll).
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EXPRESSION OF MORPHINE CPP FOLLOWING DOSES OF MDL-72222
6C0

c/:

=
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, 4.50
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Figure 16 Mean time that rats spent (seconds) in the morphine-paired

chamber (+SEM)' of the CPP apparatus on test day. Thirty min following
MDL-72222 (0.0. 0.17, 0.5. ^1.5,, 4.5 mg/kg. IP) treatment each 17-day-oId
rat pup was allowed 900 sec access to. the three compartments (n=6-10).
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expression OE GOCAINE CP? FOLLOWING DOSES OF
72222
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.Elgure_l_L Mean , time: that rats .spent (seconds) in the cocaine-paired
chamber (-J-SE.VI) of the CPF apparatus on test day,. Thiny min following
MDL-72222 (0.0, 0.17. 0.5, 1.5. 4.5 mg/kg, IP) treatment each I7-day-dld
rat pup was allowed 900 sec access to the /three, compartment (7-10).
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Surprisingly, test day treatment with MDL did affect compartment

preference in saline-conditioned rats (see Figure 18). Post hoc

comparisons using Tukey tests (jP < .05), showed that rats receiving the
4.5 mg/kg MDL-72222 exhibited a compartment preference.
Importantly, morphine and cocaine did produce a place

preference (see Figures 19 and 20). Rats treated with 0.5 mg/kg of
morphine spent significantly more total time in the drug-paired
chamber when compared to saline treated rats, t (15)= -3.35, P. < .05.

Similarly, the cocaine group spent significantly more total time in the
drug-paired compartment than did rats receiving saline alone, t (14)= 
2.77, P < .05.
Snmmarv

MDL-72222, at dosage levels of 0.17 to 4.5 mg/kg, did not

significantly affect the expression of morphine- or cocaine-induced CPP.
Whereas, morphine or cocaine (given without MDL-72222) was able to
induce CPP. Surprisingly, MDL-72222 (at the highest dose) did produce a
compartment

preference.
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EXPRESSION.OF MORPHINE CPP
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00
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spent (seconds) in the preferred chamber (+SEM) by

saline- or morphine-treated rat pups on test day. The 17-day-old fats
were placed into the CPP apparatus 30 min following saline injections and
allowed 900 sec access to all three compartments (n=7-M).
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EXPRESSION Or COCAiNS GPP
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Figure 20. Mean time spent (seconds) in the preferred chamber (+SEM) by

saline- or cocaine-treated rat pups on test day. The 17-day-oId rats were
placed into the GPP apparatus 30 min following saline injections and
allowed 900 sec access to all three compartments (n=7-9).
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EXPERIMENT2

Method

Subjects. Total subjects numbered 84 (n=7). Otherwise the subjects

and apparatus were the same as described in Experiment 1.
Procedure and Dru^s. Rat pups were given two 30 min conditioning
trials on each of the two cohsecutiye days. On the first conditioning day,

the rats were given two saline injections and placed in a novel scented
compartment for 30 min. This was repeated 4 hours later. On the second
day, n-day-old rat pups were injected i.p. with saline or the selective

serotonin 5-HT3 receptor antagonist MDL-72222 (0.5, 1.5, 4.5 mg/kg).
Thirty minutes later rats were given a second injection (i.p.) of saline,

cocaine (20 mg/kg) or morphine (0.5 mg/kg), placed in a chamber for 30

min, and presehted With a novel odor. The identical procedure was
repeated four hours later. Importantly, drug treatment and chamber
scent (lemon or almond) were counter-balanced so that scent alone
would not confound results (see Figure 21) for a summary of this
experiment)
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ACQUISITION Experiment
Systemic Injections
(MDL72222 Given Pre-conditioning)
.■Drugs, '.

MDI,,72222

MDL72222

MDL72222

,MDL72222

0.0 : mg/kg';, . ;C.5 mg/kg

1.5 mg/kg

4.5 mg/kg

i.p.

i.p.

Coc 20.0

mg/kg i.p.
Mqrph 0.5

mg/kg i.p.
Saline i.p.

Figt3r-g» 91 Protocol Design of Acquisition Experiment.
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i.p.

i.p.

Following the two days of CPP conditioning, rat pups were injected with
saline and were given free access to both scented chambers for 15 min.

Pups conditioned with cocaine-alone or morphine-alone should prefer

the drug-paired compartment. It was predicted that MDL-72222 would
block the acquisition of this cocaine- and morphine-induced preference.
Rcshlts

Locomotor Activity. The mean locomotor activity counts of

morphine-, cocaine-, and saline-treated rats are shown in Figure 22, 23

and 24). Each rat pup had received a dose of MDL-72222 (0.0, 0.5, 1.5,
4.5 mg/kg, IP) 30 min prior to the drug injections. Overall, cocainetreated rats had sighificantly more line-crosses than saline- or morphinetreated rats, E (2,72)= 90.19, E < .05 (see Figure 23). MDL-72222 did not
affect the locomotor activity of the morphine-, cocaine-, or saline-treated
rats.

Conditioned Place Preference. MDL-72222 (0.17, 0.5, 1.5, 4.5 mg/kg,

IP) failed to significantly block the acquisition of either morphine- or
cocaine-induced CPP in 17-day-old rats (see Figures 25 and 26). More

specifically, MDL-72222 given prior to injections of morphine (0.5 mg/kg,
IP) or cocaine (20.0 mg/kg, IP) during conditioning did not affect

compartment preference on the test day, F(3,24)= .02, P>.05; F(3,24)= .35,
E>.05; respectively.
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E^1h:^_22. Mean number (+SEM) of

compartment of the CPP apparatus during both conditioning sessions (30
rnin each). The I7-day-qId rat pups were injected with morphine (0.5
mg/kg, IP), or saline 30 rnin following a dose of MDL72222 (0.0, 05, 1 5

4.5 mg/kg, IP) and placed into the conditioning chamber(n=:7)
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LOCOMOTOR ACTIVITY
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Figure 23- Mean number (+SEM) of line-crosses in the drug-paired
compartment of the CPP apparatus during both conditioning sessions (30
min each). The 17-day-old rat pups were injected with cocaine (20.0
mg/kg, IP), or saline 30 min following a dose of MDL72222 (0.0, 0.5, 1.5
4.5 mg/kg, IP) and placed into the conditioning chamber (n=7)
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effect of MDL-72222 ON THE ACQUISITIOxN
OF MORPHINE GPP
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Ej^ure_22. Mean time that rats spent (seconds) in the ^morphine-paired
chamber (-i-SEM) of the CPP apparatus on test day; On the previous day,
each 17-day-old rat pup was given .VIDL7:222 (0.0. 0.5. 1.5, 4.5 ms/ks. IP)
30 min prior to an injection of.saline or. morphine (0.5 mg/kg, IP) and
allowed 900 sec access to the three compartments (n-=7y .
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EFFECT OF MDL-72222 ON THE ACQUISITION
OF COCAINE CPP
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Figure 26. Mean time that rats spent (seconds) in the cocaine-paired
chamber (+SEM) of the GPP apparatus on test day. On the previous day,
each 17-day-old rat pup, was given MDL72222 (0.0. 0.5. 1.5, 4.5 mg/kg. IP)

30 min prior to an injection of saline or cocaine (20.0 mg/kg. IP), and
allowed 900 sec access to the three compartments in=7).
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Treatment with MDL-72222 did not affect compartment preference in
saline-conditioned rats, F(3,24)= .85, £>.05 (see Figure 27).

On the test day, rat pups showed only a nonsignificant preference

for the morphine- or cocaine-paired chamber, t(12)=l.12, £>.05;
t (12)=.55, £>.05 respectively (see Figures 25 and 26).
Summarv

MDL-72222, at dosage levels of 0.5 to 4.5 mg/kg, did not

significantly affect the acquisition of morphine- or cocaine-induced CPP.
In contrast to Experiment 1, MDL-72222 did not affect compartment

preference or action based on cocaine-induced locomotor activity.
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EFFECT OF MDL.72222 ON THE ACQUISITION
OF A PLACE PREFERENCE
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i^ure 27. Mean time that rats spent (seconds) in the saline-paired
chamber (-t-SEM) of the CPP apparatus on test day. On the previous dav,
each 17-day-oId rat pup was given MDL72222 (0 0. 0.5. 1.5. 4.5 mg/kg, IP)
T*. '

'

^

SO rnin prior to an injection of saline and allowed 900 sec access to the
three compartments (n=7).
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DISCUSSION

Although there is much evidence to show that the dopamine

system in the adult rat is modulated by 5-HT3 receptors (Higgins et al.,
1992; Imperato & Angelucci, 1989; Pel et al., 1989; Suzuki et al., 1993),
this is the first study to examine the role, if any, played by 5-HT3

receptors on the reward processes of the preweanling rat. The results of
the present study suggest that the 5-HT3 receptor system may

differentially modulate DA- and opioid-mediated reward across

ontogeny. More specifically, 5-HT3 receptor antagonists block the
cocaine- and morphine-induced CPP of adult rats, while a 5-HT3

antagonist did not block CPP in preweanling rats. There are two probable
explanations for these results. First, the 5-HT3 receptors of preweanling
rats may not modulate DA reward in the same manner as in the adult
rat. This has not been adequately examined, although it is known that 5

HT3 receptors are present and functional shortly after birth (Boess &
Martin, 1994; Daval et al., 1987; Hard & Engel, 1988; Johansson-Wallsten

et al., 1993; Pranzatelli et al., 1992; 1994). Second, 5-HT3 antagonists

may differentially affect the Di or D2 receptors of preweanling rats.
Previous research indicates that the DA receptor subtypes of preweanling

rats differ in density and expression from those found in adult rats
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(McDougall et sA., l99i^; 1992; Murrin, Gibbens, & Ferrer, 1985; Murrin &
Zeng, 1989; 1990; Zeng et al., 1988).

Importantly, the preseiit results demonstrate that both morphineand cocaine-treated 17-day-old rats showed a robust place preference

using the abbreviated CPP procedure. Surprisingiyv this study also clearly
demonstrates the inability of MDL-72222 (047, 0.5, 1-5, 4.5 mg/kg, IP) to

significantly block either the expression or acquisition of cocaine- and
morphine-induced GPP in 17-day-old rats. This differs from previous
studies using adult rats which have shown that 5-HT3 antagonists block

the initial acquisition of a rewarded behavior (Bilsky & Reid, 1991;
Carboni et al., 1989; Higgins etal., 1992). More specifically, niany 5-HT3
antagonists, including Ml)L-72222^ have been repeatedly used to
attenuate the acquisition of reward, including morphine- and cocaineinduced CPP (Blandina et al., 1983; 19?9; Gostall et al., 1987; Dyr &
Kostowski, 1995; Gifford & Wang, 1994; Grant, 1995). The inability of

MDL-72222 to affect CPP in the present study was particularly

unexpected because research has suggested that serotdnin levels and 5
HT receptor subtypes are present and/or functional shortly after birth
(Boess & Martin, 1994; Daval et al., 1987; Hard & Engel, 1988; JohanssonWallsten et al., 1993; Pranzatelli et al., 1992; 1994). Significantly,

research into dopamine receptor functioning across ontogeny has
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demonstrated that differences exist between adult and pre-adult

responses within the dopamine system (McDougall et al., 1991; 1992;
Murrin et al., 1985; Murrin & Zeng, 1989; 1990; Zeng et al., 1988).

Additionally, it was unexpectedly discovered that saline-treated
rats given 4.5 mg/kg MDL-72222 on the test day had a significant

preference for the compartment used on the previous conditioning day
(see Figure 18). This was probably a spurious result since MDL-72222 did
not induce CPP when given during conditioning (see Figure 27).
The release of dopamine is believed to be essential for associative

learning to take place during rewarding experiences (Wickens, Begg, &
Arbuthnott, 1996). However, there has been some disagreement

pertaining to the differential involvement of Di and D2 receptors in the
reward processes of both adult and young rats. Some research using
adult rats has suggested that both the Di and D2 receptors are essential

for the acquisition of reward (Miller et al., 1990; Nakajima & Baker, 1989;
Nakajima & McKenzie, 1986; Wise & Rompre, 1989). In contrast,

Shippenberg et al. (1993) have demonstrated that the rewarding effects
of opioids, such as morphine, are primarily dependent upon activation
of Di post-synaptic receptors located within the NA.

Similarly, using

adult rats, Hiroi and White (1991a) have demonstrated a differential

involvement of dopamine Di and D2 receptor subtypes during the
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expression and acquisition of dopaniine-induced agonist reward. Hiroi
and White (1991a) found that D2 receptqr antagonism failed to block the

expression of amphetamine-induced CPP. However, expression of a
previously established CPP wa? blocked by a post-conditioning treatment
of a Di antagonist. They also found that the expression of reward by Di

receptors takes place within the NA, which has connections to the
amygdala.

the different roles played by Di or D2 dopamine receptors in the

preweanling rat may explain why 5-HT3 antagonists did not affect
reward processes. Quantitative autoradiographic assessment of
dopamine Di and D2 receptors has shown that these DA receptor

subtypes differ in their quantity and im|)act on the reward system
during various developmental stages (McDougall et al., 1991; 1992;
Murrin, Gibbens, & Ferrer, 1985; Murrin & Zeng, 1986; 1989; 1990; Zeng et

al., 1988) (see Figures 28 and 29). Importantly, preweanlings rats exhibit

regional brain differences in receptor density when compared to other
developmental time periods. For example, preweanling rats possess a

greater number of D2 receptors in the NA, as compared to other forebrain
regions (Broaddus & Bennett, 1990; DeVries, Mulder & Schoffelmeer, 1992;
Gelbard et al, 1989; McDougall et al., 1991; Murrin & Zeng, 1989; 1990;

Zeng, Hyttel & Murrin, 1988). Additionally, McDougall et al. (1991)

found that 17-day-old rats not only have a higher density of D2 receptors
in the NA, but that they respond differently to D2 antagonism when

compared to other age levels. Pruitt et al. (1995) also found a differential
rate of receptor functioning and reward responsiveness across ontogeny
in a cocaine GPP study assessing the antagonism Of reward by Di and D2

receptor blockade. Importantly, they showed that D2 antagonists did not
block cocaine-induced GPP in 17-day-old rats. It was concluded that Di

receptors are responsible for mediating reward in this age group.
Preweanling rats show a Di and D2 dopamine receptor ratio of 1:2
in the NA. In contrast, D2 receptor levels maintain a steady increase

during development, whereas Dj receptors show a sudden increase,

peaking just before and following weaning (Gelbard et al., 1989; Murrin
& Zeng, 1990). Using Diand D2 receptor antagonists to block GPP at
various ages, Pruitt et al. (1995) concluded that Di receptors are

critically involved in the reward processes of preweanling rats, especially

during this peak increase. Specifically, when Di receptor density is low,
as it is in adult and 10-day-old rats, D2 receptor blockade appears to be

more effective in antagonizing DA reward. Nonetheless, it has been
concluded that Di and D2 receptors may be coupled in reward processes

(Pruitt et al., 1995). Thus, each receptor
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subtype cooperates in an

interactive manner to provide tonic motor (D2) S-nd reward sensations

(Di) that are necessary for the full expression of the reward system (see
also Wickens et al., 1996). This may explain the findings in the current

study, which showed that 5-HT3 receptor antagonism failed to affect DA
reward in preweanling rats. The sudden increased peak affect of the Di

receptor just prior to and following weaning may have prevented the
blockade of reward by the S-HTs antagonist (see Figures 28 and 29).

Additionally, the role played by memory in conditioned learning
is currently being reduced to the level of receptors, as researchers

attempt to determine the importance of receptor subtypes for the
establishment and retrieval of memory (Pesimone, 1995). Dppainine

receptors have been implicated in short-ternt memory and NMDA and
AMPA receptors appear to mediate stimulus^affect associations, whereby

an animal recognizes aiid evaluates the biological significance of the
stimulus (Ono et al, 1995). The retention of the memory of a rewarding

experience is believed to be processed within the amygdala (Hiroi &
White 1991a; Ono et al, 1995). This brain structure has a high density of

Di receptors (Hiroi & White, 1991a; 1991b), and the globus pallidus
which connects the NA to the amygdala, is also high in Di receptors
(Murrin & Zehg, 1990).
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Regional Developmental Differences in D1 Density
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(Adapted from Murrin & Zeng, 1990).
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The differential development of dopaniine receptor subtypes have
also been found to occur in humans and primates (Hyttel & Amt, 1986;
Williams & Goldman-Rakic, 1995). Specifically, dopamine Di receptors
have been correlated with certain types of memory and children

demonstrate peak densities of these receptors during developmental

stages when learning has been shown to be especially accelerated
(Desimone, 1995; Williams & Goldman-Rakic, 1995).

Along with a developmental increase in memory capacity in
children ages 4 to 10 years old, there is a concomitant and temporary
excess of Di,as compared to D2,dopamine receptors at this mentally .

accelerated age-range in humans (Hyttel & Amt, 1986).
As mentioned before, the Di dopamine receptor sites of rats

increase dramatically in number on those days just prior to, and

following, the weaning period; whereas, D2 receptor density (believed to

be important for activity) is greater within the striatum during this time
(Broaddus & Benneitt, 1990; DeVries et al., 1992; Gelbard et al., 1989;

Murrin & Zeng, 1986; 1990) (see Figure 28). Although speculative, this

may relate to an increased need for the experience of reward, the
retention of its memory, and its retrieval, possibly through the
activation of increased Di receptors, located within the amygdala and

surrounding regions (Hiroi & White, 1991b) (see Figure 30).
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IhppoeanTpns

The amygdala is believed to be involved in emotionally charged

mnemonic proce|sses, playing a large role in conditioned associative

learning (Hiroi k White, 1991b; Ono et al., 1995). A rat pup that is
nearing the weaning stage needs to more readily retrieve the previously
learned connections between rewarding experiences and associated

stimuli; the memory of how that reward was obtained.

Its' survival

depends upon an increased ability tq leam, and to retrieve these
memories in the absence of the nurturing mother.

The increase in Di receptors at this critical developmental period

provides a plausible explanation for the inability of 5-HT3 antagonists to
suppress the expression and acquisition of reward in preweanling rats.

Receptors capable of suppressing reward at this precarious
developmental period must necessarily be tempered.
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CONCLUSION

The results of the present study indicate that 5-HT3 receptor

functioning differs between preweanling and adult rats. While 5-HT3

receptors modulate reward processes of adult rats, they appear to have
little effect on the reward functioning of preweanling rats. This may be

due to the increased importance of Di receptor functioning at this
critical stage of life.

The differential involvement of Di and D2 receptors in the

expression and acquisition of reward processes in adults, implies that D2
receptors have an increased importance in the acquisition of reward,
while Di receptors function in the expression of reward (Hiroi & White,
1991a; 1991b). The receptors involved in memory processes that occur in
relation to the acquisition and expression of conditioned learning is an
important area for further research.

Until the present study, there have been no studies examining the
role of 5-HT3 receptors for the expression or acquisition of reward in

preweanling rats. Our findings demonstrate the inability of the specific
5-HT3 antagonist MDL-72222 to block the expression and acquisition of

morphine- and cocaine-induced reward and I believe that this may be
related to the ontogenetic peak of Di receptors which occurs in the
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preweanling rat (Broaddus & Bennett, 1990; DeVries, Mulder,
Schoffelmeer, 1992; Hiroi & White, 1991a; 1991b; Murrin & Zeng,
1986;1990; Pniitt et al., 1992).

However, it is important to replicate these results by using

different experimental designs. Our finding that 5-HT3 antagonism fails
to attenuate preweanling DA reward, obviously differs from the adult rat

suggesting many other possibilities. The preweanling rat may possess 5
HT3 receptors that are too immature to respond to the antagonist at the

dosage levels tested. Similarly, 5-HT3 antagonism using the abbreviated
CPP paradigm, should be repeated in adult rats in order to rule out any

spurious differences found in this current study. Possibly, a different
paradigm such as the standard CPP procedure or the operant
conditioning paradigm could produce differing results. Similarly, the

injection of different levels of 5-HT3 antagonist

drug may produce a

different response in the preweanling rat.
Further research is needed to identify the mechanisms involved in

serotonin modulation of reward in this age group. However, it remains

that the inability of MDL-72222 to block expression of CPP may not be

generalizable to adult rats. This is particularly likely, since various 5-HT3
antagonists, including MDL-72222, block the acquisition of reward in
adult rats (Blandina et al., 1983; 1989; Costall et al., 1987; Dyr &

■

. 97'

Kostowski, 1995; Gilford & Wang, 1994; Grant, 1995; Higgins et al., 1992;
Imperato & Angelucci, 1989).
In eontrast to adult rats, the present study indicates that 5-HT3

antagomsts may be incapable of blocking the acquisition or expression of

reward in preweanling rats. I believe that the peak occurrence of Pi
receptors at this period of development is related to the inability of the
5-HT3receptor antagonist to block morphine- and cocaine-induced
reward. The temporary surge of Di receptors in preweanling rats, as

compared to D2 receptors, may have developed as a survival trait that
acts to enhance the retrieval of conditioned associations for the memory
of the sensation and the source of the reward. This is the time in rat

development when the ability to form these associations is particularly
important for the survival of the animal, as maternal nourishment is
withheld. Survival of the individual depends upon learning the

associations necessary for successful foraging behavior. Reward is an
integral aspect of this learning.
Further research is needed to confirm the specific effects that 5-HT3

receptor antagonists have on Pi receptors, and the specific role, if any,
that 5-HT3 receptors have in the reward processes of preweanling rats.

The current study confirms that 5-HT3 receptors differentially affect the

acquisition and expression of PA reward across ontogeny.
■ 9'8 ■ ■
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